Schedule 13G ownership disclosure

FIVE PRIME THERAPEUTICS INC

Security class unavailable · CUSIP: 33830X104

Event date: 2019-11-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,280,750
Percent of class
3.5200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-19-000481
Form type
SC 13G/A
Filer
FIVE PRIME THERAPEUTICS, INC.
CIK
CIK 1175505
Filed
Dec 09, 2019
Reporting period
Nov 29, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub